ConductScience.org, home

Paper6984352

Natural cell-mediated cytotoxicity in vitro and inhibition of tumor growth in vivo by murine lymphoid cells cultured with T cell growth factor (TCGF).

Kedar E and 3 others. Cancer Immunol Immunother, 1982. Cited by 40 papers, by iCite.

Cite this record

ConductScience Library. Natural cell-mediated cytotoxicity in vitro and inhibition of tumor growth in vivo by murine lymphoid cells cultured with T cell growth factor (TCGF). Papers, record 6984352. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6984352

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Natural cell-mediated cytotoxicity in vitro and inhibition of tumor growth in vivo by murine lymphoid cells cultured with T cell growth factor (TCGF).
PubMed
Journal
Cancer Immunol Immunother
PubMed
Year
1982
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
40
iCite
Relative citation ratio, by iCite
1.1
iCite
Revised in PubMed
2024-04-26
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kedar EE
2Ikejiri BLB L
3Gorelik EE
4Herbermann RBR B

Source PubMed

Download CSV of authors

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cytotoxicity, ImmunologicMajor topic
ImmunotherapyMajor topic
Interleukin-2Major topic
Lung NeoplasmsMajor topic
Mammary Neoplasms, ExperimentalMajor topic
T-LymphocytesMajor topic
Animals
Cell Line
Cells, Cultured
Drug Evaluation, Preclinical
Female
Humans
Male
Mice
Mice, Inbred Strains
Neoplasms
Neoplasms, Experimental
Rosette Formation

Source PubMed

Download CSV of topics

References33

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
16968245In vitro growth of murine T cells. IV. Use of T-cell growth factor to clone lymphoid cells.Cell Immunol1980https://conductscience.org/library/papers/6968245PubMed
26984388A rapid technique for isolation of viable tumor cells from solid tumors: use of the tumor cells for induction and measurement of cell-mediated cytotoxic responses.Eur J Cancer Clin Oncol1982https://conductscience.org/library/papers/6984388PubMed
36989911In vitro growth of cytotoxic human lymphocytes. II. Use of T cell growth factor (TCGF) to clone human T cells.J Immunol1980https://conductscience.org/library/papers/6989911PubMed
4224318Continuous culture of T cells cytotoxic for autologous human leukaemia cells.Nature1979https://conductscience.org/library/papers/224318PubMed
56164729Murine NK cell cultures: effects of interleukin-2 and interferon on cell growth and cytotoxic reactivity.J Immunol1981https://conductscience.org/library/papers/6164729PubMed
6309484In vitro growth of murine T cells. I. Production of factors necessary for T cell growth.J Immunol1978https://conductscience.org/library/papers/309484PubMed
76966652In vitro growth of murine T cells. V. The isolation and growth of lymphoid cells infiltrating syngeneic solid tumors.J Immunol1980https://conductscience.org/library/papers/6966652PubMed
8376742Evidence that natural cytotoxicity and antibody-dependent cellular cytotoxicity are mediated in humans by the same effector cell populations.J Immunol1979https://conductscience.org/library/papers/376742PubMed
96165306Role of interferon in regulation of cytotoxicity by natural killer cells and macrophages.Ann N Y Acad Sci1980https://conductscience.org/library/papers/6165306PubMed
106154658In vivo natural reactivity of mice against tumor cells.Int J Cancer1980https://conductscience.org/library/papers/6154658PubMed
116168724On the heterogeneity of murine natural killer cells.J Exp Med1981https://conductscience.org/library/papers/6168724PubMed
12368247Evaluation of the role of IgG antibodies in human natural cell-mediated cytotoxicity against the myeloid cell line K562.J Immunol1979https://conductscience.org/library/papers/368247PubMed
136161166Continuous cytotoxic T cell lines reactive against murine plasmacytoma tumor-associated antigens.J Immunol1981https://conductscience.org/library/papers/6161166PubMed
146166701Characteristics of human large granular lymphocytes and relationship to natural killer and K cells.J Exp Med1981https://conductscience.org/library/papers/6166701PubMed
157252408Cloned cell lines with natural killer activity. Specificity, function, and cell surface markers.J Exp Med1981https://conductscience.org/library/papers/7252408PubMed
166448800Quantitation and cloning of cytolytic T lymphocytes and their precursors.Immunol Rev1980https://conductscience.org/library/papers/6448800PubMed
176459065Expansion of autorecognitive cytotoxic effectors in human cancer by T cell growth factor (Interleukin 2)1.Arch Geschwulstforsch1981https://conductscience.org/library/papers/6459065PubMed
18307029T cell growth factor: parameters of production and a quantitative microassay for activity.J Immunol1978https://conductscience.org/library/papers/307029PubMed
197000675Clones of killer and helper T cells: growth requirements, specificity and retention of function in long-term culture.Immunol Rev1980https://conductscience.org/library/papers/7000675PubMed
20145543Long term culture of tumour-specific cytotoxic T cells.Nature1977https://conductscience.org/library/papers/145543PubMed

See all 33 referencesDownload CSV of references

Cited by14

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 40 citations.

PMIDTitleJournalYearIn PapersSource
24941370Natural killer activity: early days, advances, and seminal observations.Crit Rev Oncog2014https://conductscience.org/library/papers/24941370PubMed
22484193Advances in the treatment of metastatic melanoma: adoptive T-cell therapy.Semin Oncol2012https://conductscience.org/library/papers/22484193PubMed
11122856Vaccination for melanoma.Curr Oncol Rep2000https://conductscience.org/library/papers/11122856PubMed
6850100Large granular lymphocytes: morphological and functional properties. I. Results in normals.Blut1983https://conductscience.org/library/papers/6850100PubMed
6386143Neoplastic cells as targets of spontaneously cytotoxic lymphocytes: studies with natural killer-like cell lines.Cancer Metastasis Rev1984https://conductscience.org/library/papers/6386143PubMed
6375859Natural killer cells: artifact to reality: an odyssey in biology.Cancer Metastasis Rev1983https://conductscience.org/library/papers/6375859PubMed
6334553Antitumor and therapeutic effects of spleen cells from tumor-bearing mice cultured with T cell growth factor and soluble tumor extract.Cancer Immunol Immunother1984https://conductscience.org/library/papers/6334553PubMed
6239683Methods for amplifying the induction and expression of cytotoxic response in vitro to syngeneic and autologous freshly-isolated solid tumors of mice.Cancer Immunol Immunother1984https://conductscience.org/library/papers/6239683PubMed
6141211Successful immunotherapy of natural killer-resistant established pulmonary melanoma metastases by the intravenous adoptive transfer of syngeneic lymphocytes activated in vitro by interleukin 2.J Exp Med1984https://conductscience.org/library/papers/6141211PubMed
3873352Natural killer-like activity in human cultured lymphoid cells propagated in the presence of interleukin-2: acquired resistance to prostaglandin E2- or dexamethasone-mediated suppression.Experientia1985https://conductscience.org/library/papers/3873352PubMed
3488319
In vivo augmentation of the cytotoxicity of spleen lymphocytes against syngeneic B-16 melanoma cells and the suppression of the artificial metastases in C57BL/6 mice by subcutaneous multiple injections of high dose human recombinant interleukin-2 (rIL-2).
J Cancer Res Clin Oncol1986https://conductscience.org/library/papers/3488319PubMed
3486715Treatment of adenocarcinoma in the peritoneum of mice: chemoimmunotherapy with IL-2-stimulated cytotoxic lymphocytes as a model for treatment of minimal residual disease.Cancer Immunol Immunother1986https://conductscience.org/library/papers/3486715PubMed
2676022Lymphokine activated killer cells.Blut1989https://conductscience.org/library/papers/2676022PubMed
2425968Pronounced antitumor effect of LAK-like cells induced in the peritoneal cavity of mice after intraperitoneal injection of OK-432, a killed streptococcal preparation.Cancer Immunol Immunother1986https://conductscience.org/library/papers/2425968PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/6984352

GET https://conductscience.org/api/papers/v1/6984352/references?page=2